CNS findings in anticholinergic treated patients with overactive bladder using fMRI for functional brain imaging

被引:0
|
作者
Lebovitch, Steve
Lebed, Bett
Moonat, Shweta
Faro, Scott H.
Mohamed, Feroze
Ruggieri, Michael R.
Pontari, Michel A.
机构
来源
JOURNAL OF UROLOGY | 2008年 / 179卷 / 04期
关键词
D O I
10.1016/S0022-5347(08)61296-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:442 / 442
页数:1
相关论文
共 50 条
  • [31] Comparing anticholinergic persistence and adherence profiles in overactive bladder patients based on gender, obesity, and major anticholinergic agents
    Lua, Lannah L.
    Pathak, Prathamesh
    Dandolu, Vani
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 (08) : 2123 - 2131
  • [32] Persistence with first line anticholinergic medication in treatment-naive overactive bladder patients
    Krhut, Jan
    Gaertner, Marcel
    Petzel, Martin
    Sykora, Radek
    Nemec, David
    Tvrdik, Josef
    Skoupa, Jana
    SCANDINAVIAN JOURNAL OF UROLOGY, 2014, 48 (01) : 79 - 83
  • [33] Anticholinergic Burden in Patients With Overactive Bladder and Association With Health Outcomes: A Retrospective Claims Analysis
    Richter, H. E.
    Chastek, B.
    Carrera, A.
    Landis, C.
    Snyder, D.
    Abedinzadeh, L.
    Bancroft, T.
    Nesheim, J.
    Dmochowski, R.
    Hijaz, A.
    Frankel, J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 : S157 - S157
  • [34] OVERACTIVE BLADDER MEDICATION COMPLIANCE WHEN PATIENTS CO-PAY THE ANTICHOLINERGIC AGENTS
    Zahariou, A.
    Papaioannou, P.
    Stavrou, A.
    Kyriades, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 249 - 249
  • [35] THE RISK OF COGNITIVE IMPAIRMENT IN PATIENTS STARTING ANTICHOLINERGIC MEDICATIONS FOR OVERACTIVE BLADDER: A PROSPECTIVE TRIAL
    Iyer, Shilpa
    Botros, Carolyn
    Lozo, Svjetlana
    Eng, Joshua
    Sand, Peter
    Tomezsko, Janet
    Botros, Sylvia
    Gafni-Kane, Adam
    Sasso, Karen
    Goldberg, Roger
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 : S607 - S607
  • [36] Anticholinergic burden in the Japanese elderly population: Use of antimuscarinic medications for overactive bladder patients
    Yoshida, Masaki
    Kato, Daisuke
    Nishimura, Takuya
    Van Schyndle, James
    Uno, Satoshi
    Kimura, Tomomi
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (10) : 855 - 862
  • [37] The risk of cognitive impairment in patients starting anticholinergic medications for overactive bladder: a prospective trial
    Iyer, S.
    Botros, C.
    Lozo, S.
    Eng, J.
    Sand, P.
    Tomezsko, J.
    Botros, S.
    Gafni-Kane, A.
    Sasso, K.
    Goldberg, R.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2018, 29 : S45 - S45
  • [38] CHANGES IN BRAIN ACTIVITY ON FUNCTIONAL MAGNETIC RESONANCE IMAGING DURING SACRAL NERVE STIMULATION FOR OVERACTIVE BLADDER
    Gill, Bradley C.
    Pizarro-Berdichevsky, Javier
    Bhattacharyya, Pallab
    Marks, Brian K.
    Quirouet, Adrienne
    Vasavada, Sandip P.
    Jones, Stephen
    Goldman, Howard B.
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S143 - S144
  • [39] BRAIN ACTIVITY CHANGES ON FUNCTIONAL MAGNETIC RESONANCE IMAGING DURING SACRAL NERVE STIMULATION FOR OVERACTIVE BLADDER
    Gill, Bradley
    Pizarro-Berdichevsky, Javier
    Bhattacharyya, Pallab
    Marks, Brian
    Quirouet, Adrienne
    Vasavada, Sandip
    Jones, Stephen E.
    Goldman, Howard B.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1045 - E1045
  • [40] Is self-reported adherence associated with clinical outcomes in women treated with anticholinergic medication for overactive bladder?
    Andy, Uduak U.
    Arya, Lily A.
    Smith, Ariana L.
    Propert, Kathleen J.
    Bogner, Hillary R.
    Colavita, Kristen
    Harvie, Heidi S.
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 (06) : 738 - 742